We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+23.27%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$11.9B
AUM Growth
-$665M
Cap. Flow
-$2.07B
Cap. Flow %
-17.42%
Top 10 Hldgs %
29.25%
Holding
1,790
New
534
Increased
200
Reduced
243
Closed
613

Top Sells

Rank Stock Value
1
TSM icon
TSMC
TSM
+$107M
2
GSK icon
GSK
GSK
+$58.9M
3
AVGO icon
Broadcom
AVGO
+$54M
4
UL icon
Unilever
UL
+$54M
5
MRVL icon
Marvell Technology
MRVL
+$48.3M

Sector Composition

Rank Sector Weight
1 Technology 11.5%
2 Communication Services 3.61%
3 Financials 3.6%
4 Healthcare 3.01%
5 Consumer Discretionary 1.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TSLA icon
51
PUT
Tesla
TSLA
$1.24T
$37M 0.31%
91,600
-277,600
-75% -$89.3M
AVGO icon
52
Broadcom
AVGO
$1.82T
$36.5M 0.31%
157,602
-291,955
-65% -$54M
FSLR icon
53
CALL
First Solar
FSLR
$21.8B
$36.5M 0.31%
207,200
+111,800
+117% +$22.3M
FLEX icon
54
Flex
FLEX
$43.4B
$36.5M 0.31%
+950,000
New +$35.2M
AMED
55
DELISTED
Amedisys
AMED
$36.4M 0.31%
401,384
+137,838
+52% +$12.7M
ACI icon
56
CALL
Albertsons Companies
ACI
$5.4B
$36.4M 0.31%
1,855,400
-1,275,700
-41% -$24.2M
GLD icon
57
PUT
SPDR Gold Trust
GLD
$131B
$36.3M 0.31%
+150,000
New +$36.9M
WDC icon
58
PUT
Western Digital
WDC
$179B
$34.8M 0.29%
771,706
-25,798
-3% -$1.3M
MRVL icon
59
Marvell Technology
MRVL
$174B
$33.6M 0.28%
304,347
-520,653
-63% -$48.3M
QQQ icon
60
Invesco QQQ Trust
QQQ
$455B
$33.5M 0.28%
65,506
+53,969
+468% +$27.3M
INFY icon
61
Infosys
INFY
$45B
$32.9M 0.28%
1,498,790
-472,210
-24% -$10.6M
MSFT icon
62
Microsoft
MSFT
$2.84T
$32.7M 0.28%
77,571
+24,270
+46% +$10.3M
CORZW icon
63
Core Scientific Inc Tranche 1 Warrants
CORZW
$1.57B
$32.3M 0.27%
+3,924,298
New +$35.5M
ANSS
64
DELISTED
Ansys
ANSS
$31.2M 0.26%
92,616
-484
-0.5% -$162K
PLTR icon
65
PUT
Palantir
PLTR
$295B
$31M 0.26%
+410,000
New +$23.9M
AMD icon
66
Advanced Micro Devices
AMD
$851B
$30.7M 0.26%
254,393
+27,443
+12% +$3.95M
AMGN icon
67
PUT
Amgen
AMGN
$203B
$29.6M 0.25%
113,600
-55,800
-33% -$16.6M
CSCO icon
68
Cisco
CSCO
$450B
$29.5M 0.25%
498,770
+298,770
+149% +$17.1M
CMPOW
69
DELISTED
CompoSecure Inc Warrant
CMPOW
$27.5M 0.23%
+5,922,896
New +$27.3M
WDC icon
70
Western Digital
WDC
$179B
$27M 0.23%
598,893
+522,647
+685% +$26.3M
TSLA icon
71
CALL
Tesla
TSLA
$1.24T
$26.9M 0.23%
66,600
-143,600
-68% -$46.2M
X
72
PUT
DELISTED
US Steel
X
$26.7M 0.22%
786,700
-29,100
-4% -$1.07M
HCP
73
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
$26.2M 0.22%
765,348
-22,070
-3% -$748K
LW icon
74
Lamb Weston
LW
$6.82B
$25.7M 0.22%
385,000
+234,000
+155% +$17.5M
PDD icon
75
PUT
Pinduoduo
PDD
$118B
$25.3M 0.21%
260,800
+68,800
+36% +$8M

Similar funds

LMR Partners's Q4 2024 Portfolio in Review

As of Q4 2024, LMR Partners held 1,790 positions worth $11.9B, down 5.3% from $12.6B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

LMR Partners withdrew a net $2.07B in Q4 2024, closing 613 positions and reducing 243 holdings. Its most notable exit was Unilever, an estimated $54M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Communication Services and Financials.

Against the trend, LMR Partners opened a new position in Vertex Pharmaceuticals worth $37.8M.

  • LMR Partners's largest Q4 2024 buy was Vertex Pharmaceuticals: 93,801 shares worth $37.8M.
  • LMR Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2024, an estimated $472M increase.
  • LMR Partners's biggest Q4 2024 reduction was TSMC, cutting an estimated $107M.
  • LMR Partners fully exited Unilever in Q4 2024, selling an estimated $54M.
  • LMR Partners's ten largest holdings make up 29% of its $11.9B portfolio in Q4 2024.
  • LMR Partners opened 534 new positions and closed 613 in Q4 2024.
  • LMR Partners's portfolio value fell 5.3% quarter-over-quarter to $11.9B.

Based on LMR Partners's 13F filing for Q4 2024, filed 14 Feb 2025.